Biosynex SA (EPA:ALBIO)
France flag France · Delayed Price · Currency is EUR
0.9200
+0.0160 (1.77%)
Jul 31, 2026, 11:05 AM CET

Biosynex Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.464.6920.1787.17132.03
Short-Term Investments
-56--
Cash & Short-Term Investments
8.469.6926.1687.17132.03
Cash Growth
-12.75%-62.96%-69.99%-33.98%258.43%
Accounts Receivable
7.827.110.6514.725.27
Other Receivables
16.4214.9410.6718.869.41
Total Trade Receivables
24.2422.0421.3133.5634.67
Inventory
22.8732.6738.2137.6731.15
Other Current Assets
--5.661.20.92
Total Current Assets
55.5664.3991.35159.61198.78
Net Property, Plant & Equipment
8.514.8516.18.745.26
Other Intangible Assets
69.24113.01131.3486.8652.13
Long-Term Investments
2.942.442.935.1412.77
Total Assets
136.24194.69241.73260.34268.94
Accounts Payable
17.1516.3115.0714.9918.73
Accrued Expenses
--9.699.3828.03
Other Current Liabilities
12.926.88---
Total Current Liabilities
30.0543.1924.7624.3746.76
Long-Term Debt
61.6562.6365.9652.0835.31
Other Long-Term Liabilities
7.664.5622.8414.9217.32
Total Long-Term Liabilities
69.3167.1888.816752.63
Total Liabilities
99.35110.38113.5691.3699.39
Common Stock
1.881.081.081.031.11
Additional Paid-in Capital
32.7825.625.625.647.27
Retained Earnings
0.2953.997.81135.91119.42
Total Common Shareholders' Equity
34.9580.58124.48162.53167.81
Minority Interest
1.943.747.548.533.51
Shareholders' Equity
36.8984.31128.17168.98169.56
Total Liabilities & Equity
136.24194.69241.73260.34268.94
Total Debt
61.6562.6365.9652.0835.31
Net Cash (Debt)
-53.19-52.94-39.835.196.72
Net Cash Growth
----63.71%359.13%
Net Cash Per Share
-2.84-4.92-3.981.7317.62
Book Value
34.9580.58124.48162.53167.81
Book Value Per Share
1.877.4912.458.0130.57
Tangible Book Value
-34.29-32.43-6.8675.67115.67
Tangible Book Value Per Share
-1.83-3.02-0.693.7321.07